Cargando…
A Therapy-Terminating Event: Programmed Death-1 Inhibitor-Induced Mucositis
Oral mucositis is a painful inflammatory response that can lead to infection, cachexia, and therapy termination. This immune-related adverse event (IRAE) has been well documented within the newly developing field of immunotherapy. This case series presents three patients, aged 73 to 81 years, who we...
Autores principales: | Foster, Dawson, Karam, Imad, Nadella, Sri, Adekunle, Deborah, Meyer, Margaret, Rana, Merra, Sokhn, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584693/ https://www.ncbi.nlm.nih.gov/pubmed/36304369 http://dx.doi.org/10.7759/cureus.29377 |
Ejemplares similares
-
Tattoo Guidelines in the At-Risk Cancer Population
por: Foster, Dawson, et al.
Publicado: (2023) -
A Rapidly Debilitating Myopathy: A Rare Case of Statin-Induced Necrotizing Myositis
por: Ahmad, Anam, et al.
Publicado: (2021) -
A Man With Intractable Back Pain, Spondylodiscitis: A Case Report of Uncommon Site of Spinal Gout
por: Karam, Imad, et al.
Publicado: (2021) -
Multiple White Plaques in the Esophagus: A Possible Case of Esophageal Mucosal Alteration Associated With Immune-Related Adverse Events of Immune Checkpoint Inhibitors
por: Iwamuro, Masaya, et al.
Publicado: (2022) -
The Effect of Pembrolizumab in Absence of Programmed Death 1 Receptor
por: Al Attar, Layth, et al.
Publicado: (2018)